Saturday 17 October 2026 Export AYTU’s income statement to Excel — free account

Aytu BioPharma, Inc.

AYTU Healthcare Drug Manufacturers Specialty & Generic

Aytu BioPharma, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $57.6 million, down 13.3% from fiscal 2025. In the quarter to June 2026, revenue grew 6.42%, EPS grew 100.0%, free cash flow grew 57.7% and total debt fell 21.9%, each against the same quarter a year earlier.

2.04 0.03 +1.49%

Follow AYTU

Alert me

Market cap: $21.8M
P/E: 0.0×
Fwd P/E: −9.2×
Dividend yield: —
F-score: 3/9
Altman Z: −4.04
Beneish M: −3.48
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	3	3	3	3
ROE Full definition →		(49.33%)	(108.72%)	(97.24%)	(52.55%)
ROA Full definition →		(10.86%)	(20.52%)	(28.87%)	(12.44%)
ROIC Full definition →		(29.63%)	(106.20%)	(31.33%)	(19.99%)
Return on Tangible Assets Full definition →		(83.70%)	(218.98%)	(438.80%)	(190.36%)
Average Days of Receivables Full definition →		190.39	180.19	157.93	144.42
Free Cash Flow per Share Full definition →		(0.14)	(0.06)	0.15	0.26
Free Cash Flow Full definition →		(1.36)	(0.55)	1.58	3.24
Capital Expenditures Full definition →		—	0.04	(0.10)	(0.05)
Other line items
Cash ROIC Full definition →		(1.65%)	(0.85%)	1.88%	4.12%
Accounts Receivable Turnover Full definition →		2.26	2.22	1.88	2.13
Accounts Payable Turnover Full definition →		1.60	1.60	1.58	1.90
Inventory Turnover Full definition →		1.89	2.10	2.15	2.27
Average Days of Payables Full definition →		218.00	250.58	241.93	198.47
Days of Inventory on Hand Full definition →		178.40	152.12	136.58	120.66
Tax Rate Full definition →		0.00	0.00	0.01	0.03
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	1.59%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		59.26%	62.41%	71.90%	74.07%
Share Based Compensation of Revenue Full definition →		0.81%	1.04%	1.16%	1.20%
Interest Coverage Full definition →		(2.60)	(3.21)	(6.76)	(4.39)
Operating CF/Net income Full definition →		0.10	0.02	(0.05)	(0.23)
Depreciation/Fixed assets Full definition →		9.91	9.40	10.77	10.50
Capex/Depreciation Full definition →		0.00	0.01	(0.02)	(0.01)
Revenue per Share Full definition →		6.75	6.24	5.38	4.67
Operating CF per Share Full definition →		(0.14)	(0.06)	0.16	0.27
Capex per Share Full definition →		0.00	0.00	(0.01)	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 2 Oct 2026

Stockrow Weekly